Shares of Peak Bio, Inc. (NASDAQ:PKBO – Get Free Report) rose 976.9% during trading on Thursday . The company traded as high as $0.15 and last traded at $0.14. Approximately 55,201 shares changed hands during mid-day trading, an increase of 678% from the average daily volume of 7,092 shares. The stock had previously closed at $0.01.
Peak Bio Trading Up 976.9 %
The business’s 50-day moving average price is $0.01 and its 200 day moving average price is $0.01.
Peak Bio (NASDAQ:PKBO – Get Free Report) last issued its quarterly earnings results on Monday, June 24th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $0.28 million for the quarter.
Peak Bio Company Profile
Peak Bio, Inc, a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with inflammatory, cancer, and rare and specialty diseases. The company's lead product candidate is PHP-303, which is in phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome.
Featured Stories
- Five stocks we like better than Peak Bio
- Best Stocks Under $10.00
- Emerging Markets: What They Are and Why They Matter
- Why Invest in High-Yield Dividend Stocks?
- Recession or Not, These 3 Stocks Are Winners
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Why NVIDIA Is More of a Screaming Buy Than Ever
Receive News & Ratings for Peak Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Bio and related companies with MarketBeat.com's FREE daily email newsletter.
